Survival group (n = 64) | Non-survival group (n = 80) | P value | |
---|---|---|---|
Gender (M/F) | 54/10 | 65/15 | NS |
Age (yrs) | 54.5 ± 10.3 | 52.0 ± 9.85 | NS |
HBsAg (Y/N) | 48/16 | 62/18 | NS |
Cirrhosis (Y/N) | 44/20 | 49/31 | NS |
Tumor Size | 4.55 ± 2.13 | 7.93 ± 3.33 | 0.000 |
Number of tumors (S/M) | 59/5 | 67/13 | NS |
AFP ≥ 400 (Y/N) | 12/52 | 43/37 | 0.0001 |
AST (U/L) | 49.9 ± 35.0 | 52.0 ± 36.3 | NS |
ALT (U/L) | 45.2 ± 21.4 | 56.2 ± 42.2 | NS |
Scr (µmol/L) | 71.1 ± 14.8 | 71.3 ± 16.2 | NS |
Hospital duration | 20.6 ± 7.03 | 21.4 ± 8.47 | NS |
Differentiation | 21/43 | 46/34 | 0.003 |
Child-Pugh Score | |||
A | 57 | 70 | 0.773 |
B | 7 | 10 | |
TMN Grade (I/II/III) | |||
I | 48 | 12 | 0.000 |
II | 16 | 21 | |
III | 0 | 47 | |
NLR | 2.80 ± 1.89 | 3.79 ± 3.29 | 0.000 |
ALBI grade | |||
I | 48 | 39 | 0.001 |
II | 16 | 41 | |
NLR-ALBI | |||
Score 1 | 34 | 17 | 0.000 |
Score 2 | 24 | 34 | |
Score 3 | 8 | 27 |